Abbott India has reported results for fourth quarter and year ended March 31, 2022.
The company has reported a rise of 38.66% in its net profit at Rs 211.41 crore for the quarter under review as compared to Rs 152.47 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 1,276.07 crore for Q4FY22 as compared Rs 1,114.74 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore as compared to Rs 690.69 crore for the previous year. Total income of the company increased by 13.79% at Rs 4,996.48 crore for year under review as compared to Rs 4,390.92 crore for year ended March 31, 2021.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |